Outpace Bio

The next generation of smart cell therapies using protein design and synthetic biology. Committed to mechanistic and structural understanding.

[Outpace Bio @OutpaceBio]

Congratulations to our Outpace bike riders for completing the 50mi course in the Fred Hutchinson Cancer Center's 10th annual #Obliteride - along with our 3 virtual participants. We are happy to support our colleagues to advance curative therapies for cancer and other diseases

[openfold @open_fold]

Please allow us to introduce ourselves - we are OpenFold https://t.co/e1YPCB0oGN, a consortium of life science & tech cos & academics democratizing AI for Biology. Founded by @MoAlQuraishi @ArzedaCo @cyrusbiotech @OutpaceBio @PrescientDesign help from @AWS https://t.co/oVWVQeCPQA

[Outpace Bio @OutpaceBio]

We're excited to contribute to OpenFold and work towards making the best ML-powered structural biology tools readily accessible and improved upon by community-driven efforts. Congrats to the AlQuraishi lab @MoAlQuraishi and OpenFold team on reaching this important milestone

[Mohammed AlQuraishi @MoAlQuraishi]

We have successfully trained OpenFold from scratch, our trainable PyTorch implementation of AlphaFold2. The new OpenFold (OF) (slightly) outperforms AlphaFold2 (AF2). I believe this is the first publicly available reproduction of AF2. We learned a lot. A🧵1/12

[Outpace Bio @OutpaceBio]

Respect and Inclusion are the foundation of our culture at Outpace. We are proud to support our LGBTQ+ colleagues and recognize that our diversity is part of what makes us successful. Happy pride month from Outpace!

[Outpace Bio @OutpaceBio]

Thanks to @NVIDIAHealth for the shoutout at GTC! Excited to continue our pioneering work in protein design for cell therapies. #GTC21

[Outpace Bio @OutpaceBio]

A snapshot from our outdoor company lunch yesterday. It’s the contribution from each individual in this photo that makes Outpace such an awesome place to work!

[Outpace Bio @OutpaceBio]

Thanks for the great @forbes piece, @CarolineSeydel! https://t.co/DuZWTJWfk8

[Outpace Bio @OutpaceBio]

We’re excited to be working with our lead investors, @ArtisVentures and Lyell Immunopharma, as well as @AbstractVC, @CivilizationVC, @Mubadala, @Playground_VC, @SahsenVentures, @wrfseattle. Welcome to the board, @vasudevbailey.

[Outpace Bio @OutpaceBio]

We’re thrilled to announce our $30M Series A financing and collaboration with Lyell Immunopharma to make better immune cell therapies for the treatment of cancer. https://t.co/bFaEihZqYu